Trial Details
AuthorisedBasic Information
| Clinical ID | c3264 |
|---|---|
| Identifier | EUCTR2009-011316-38-FR |
| Trial Title | ESSAI MULTICENTRIQUE RANDOMISE CONTROLE, AVEC DEUX GROUPES PARALLELES, EN DOUBLE AVEUGLE, COMPARANT LE FERRISATAU PLACEBO DANS LNEMIE ASSOCIEE AUX MICI AU COURS DU TRAITEMENT PAR ANTI-TNF ALPHA - FER |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD) complicated by anemia._Patient under anti-TNF alpha therapy |
| Interventions | Trade Name: FERRISAT 50mg/ml Product Name: FERRISAT Pharmaceutical Form: Solution for infusion Pharmaceutical form of the placebo: Intravenous infusion Route of administration of the placebo: Intravenous use |
Participant Information
| Sponsor | GETAID |
|---|---|
| City | - |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |